Lupin Limited has informed the Exchange regarding a press release dated October 05, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Tolvaptan Tablets.".
Press Release Oct 05 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Oct 03 2023
- Press Release Sep 29 2023
- Press Release Sep 28 2023
- Press Release Sep 22 2023
- Press Release Sep 06 2023
Later from Lupin
- Press Release Oct 12 2023
- Press Release Oct 13 2023
- Press Release Oct 23 2023
- Press Release Oct 31 2023
- Press Release Nov 02 2023
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin